Pharma-Bio Serv Q3 2026 Revenues Grow ~2% as Net Income Rises
Pharma-Bio Serv reported increasing revenues for the three and nine months ended July 31, 2026, alongside a significant improvement in net income year-over-year. The company cites strong client relationships and operational efficiencies as key drivers for the financial performance.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day